Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

New product launch

26 Feb 2025 15:16

RNS Number : 5858Y
Thruvision Group PLC
26 February 2025
 

26 February 2025

Thruvision Group plc

Thruvision Launches Next Generation AI Powered 81 Series Passive People Screening Systems

 

Thruvision (AIM: THRU, "Thruvision" or the "Group"), the leading international provider of walk- through security technology, today launches its latest series of products.

 

Thruvision is proud to introduce the 81 Series, the next generation of our world-leading people security screening technology. Designed for use in all markets, the new 81 Series represents the latest evolution in Thruvision's proven people screening technology.

 

The 81 Series features an all-new modular design with integrated touchscreen control, offering a compact, mobile, and unobtrusive solution. This cutting-edge design provides exceptional ergonomics for quick and easy deployment in a wide range of screening operations.

 

Building upon our core principles of treating subjects with respect and privacy, the 81 Series allows for the instant visualisation of threats without the need for pat-downs. Our latest space-grade technology ensures reliability and support for mission-critical operations.

 

The mobile systems enable detection-at-range with a new optional integrated battery pack, providing ultimate flexibility. Capable of screening up to 1,800 people per hour with our WalkTHRU concept of operations, the 81 Series is designed to meet the demands of high-throughput environments.

 

The system detects all materials using our latest and exclusive SmartSCREEN and DynamicDETECT AI software. Available in four models, the 81 Series supports all operation types, from border and entrance security to loss prevention.

 

We invite you to experience the future of people security screening with the Thruvision 81 Series.

 

Further InformationFor more information please visit thruvision.com or email info@thruvision.com

 

81 Series Media Assets

https://drive.google.com/drive/folders/10ybKnqQv_-o0U4dmrRRmUOKsVAGT4zdN?usp=sharing

 

About Thruvision (www.thruvision.com)

Thruvision is the leading developer, manufacturer and supplier of advanced AI-based walk- through security technology internationally. Its technology is deployed in more than 30 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using advanced AI-based detection algorithms. The Group's offices are near Oxford and Washington DC.

 

Important information

This announcement may include statements that are, or may be deemed to be, 'forward-looking statements' (including words such as 'believe', 'expect', 'estimate', 'intend', 'anticipate' and words of similar meaning). By their nature, forward-looking statements involve risk and uncertainty since they relate to future events and circumstances, and actual results may, and often do, differ materially from any forward-looking statements. Any forward-looking statements in this announcement reflect management's view with respect to future events as at the date of this announcement. Save as required by applicable law, the Company undertakes no obligation to publicly revise any forward-looking statements in this announcement, whether following any change in its expectations or to reflect events or circumstances after the date of this announcement.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPUCGPUPAGAQ
Date   Source Headline
2nd Apr 20207:40 amRNSTrading Statement
25th Nov 20197:00 amRNSInterim Results
19th Nov 20197:00 amRNSNotice of Interim Results
13th Nov 20193:28 pmRNSHolding(s) in Company
24th Oct 20197:00 amRNSSharesave option grant to Executive Director
8th Oct 20192:00 pmRNSAward of Share Options to Executive Directors
3rd Oct 20197:00 amRNSTrading Update
23rd Sep 20191:29 pmRNSResult of Annual General Meeting
23rd Sep 20197:00 amRNSContract award announcement
16th Sep 20193:36 pmRNSThruvision trialed in London Underground station
8th Jul 20192:14 pmRNSNotice of Audited Results
24th Jun 20197:00 amRNSResults for the Year ended 31 March 2019
20th Jun 20197:00 amRNSNotice of Results
22nd May 20197:00 amRNSContract award announcement
1st May 20197:00 amRNSAppointment of Finance Director
2nd Apr 20197:00 amRNSPre-close Trading Update
7th Feb 20197:00 amRNSCapital Markets Day
18th Jan 20194:02 pmRNSAward of Share Options to Executive Directors
10th Dec 20187:00 amRNSInterim Results
3rd Dec 201812:52 pmRNSNotice of Results
2nd Nov 20181:24 pmRNSTSA Concept of Operations Development Contract
3rd Oct 20187:00 amRNSTrading Update
21st Sep 20183:57 pmRNSSharesave option grant to Executive Directors
21st Sep 201810:21 amRNSAGM Statement
7th Sep 20185:10 pmRNSHolding(s) in Company
7th Sep 20185:07 pmRNSHolding(s) in Company
24th Aug 20189:19 amRNSAmendment - Holding(s) in Company
22nd Aug 201811:30 amRNSHolding(s) in Company
21st Aug 201810:52 amRNSHolding(s) in Company
20th Aug 20183:04 pmRNSHolding(s) in Company
20th Aug 20182:53 pmRNSHolding(s) in Company
9th Aug 201812:30 pmRNSAnnouncement of Results of Tender Offer
31st Jul 20189:00 amRNSHolding(s) in Company
24th Jul 201810:21 amRNSResults of General Meeting/Tender Offer
4th Jul 20187:00 amRNSProposed Tender Offer & Notice of General Meeting
26th Jun 20187:00 amRNSAudited results for the full year 31 March 2018
21st Jun 201811:26 amRNSNotice of Audited Results
1st May 20183:53 pmRNSCapital Reduction Effective
28th Mar 20183:25 pmRNSResult of General Meeting
15th Mar 20185:13 pmRNSHolding(s) in Company
15th Mar 20182:00 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAward of Share Options to Executive Director
13th Mar 20185:29 pmRNSHolding(s) in Company
13th Mar 20183:40 pmRNSHolding(s) in Company
13th Mar 20183:17 pmRNSHolding(s) in Company
12th Mar 20182:05 pmRNSSecond Price Monitoring Extn
12th Mar 20182:02 pmRNSPrice Monitoring Extension
12th Mar 20187:01 amRNSShare Premium Account & Capital Redemption Reserve
12th Mar 20187:00 amRNSTrading Update & Return of Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.